{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:35:58Z","timestamp":1791495358224,"version":"4.3.4"},"reference-count":33,"publisher":"The Editorial Office of Gut and Liver","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut Liver"],"published-print":{"date-parts":[[2016,3,23]]},"DOI":"10.5009\/gnl15186","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T20:57:45Z","timestamp":1444942665000},"page":"303","source":"Crossref","is-referenced-by-count":16,"title":["A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer"],"prefix":"10.5009","volume":"10","author":[{"given":"Kyong Joo","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong In","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Jae","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Youp","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungmin","family":"Bang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-woo","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sil","family":"Seong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Young","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2920","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1200\/JCO.2008.19.7921","article-title":"Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review","volume":"27","author":"Huguet, F","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial","volume":"29","author":"Loehrer, PJ","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1200\/JCO.2007.15.8634","article-title":"Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head","volume":"26","author":"Evans, DB","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/annonc\/mdp015","article-title":"Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review","volume":"20","author":"Le Scodan, R","year":"2009","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1748-717X-5-64","article-title":"The role of radiotherapy in multimodal treatment of pancreatic carcinoma","volume":"5","author":"Brunner, TB","year":"2010","journal-title":"Radiat Oncol"},{"key":"ref6","first-page":"Array","article-title":"Role of radiation therapy in patients with resectable pancreatic cancer","volume":"25","author":"Palta, M","year":"2011","journal-title":"Oncology (Williston Park)"},{"key":"ref7","first-page":"216","article-title":"Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose","volume":"6","author":"Wilkowski, R","year":"2005","journal-title":"JOP"},{"key":"ref8","first-page":"136","article-title":"Preoperative therapies for resectable and borderline resectable pancreatic cancer","volume":"2","author":"Varadhachary, GR","year":"2011","journal-title":"J Gastrointest Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5009\/gnl.2013.7.1.106","article-title":"Gastrointestinal hemorrhage after concurrent chemoradiotherapy in locally advanced pancreatic cancer","volume":"7","author":"Lee, KJ","year":"2013","journal-title":"Gut Liver"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijrobp.2011.12.026","article-title":"Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy","volume":"84","author":"Nakamura, A","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"ref11","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"Kavanagh, BD","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijrobp.2009.10.043","article-title":"Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers","volume":"79","author":"Yovino, S","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0973-1482.29825","article-title":"Intensity modulated radiotherapy in abdominal malignancies: our experience in reducing the dose to normal structures as compared to the gross tumor","volume":"2","author":"Kataria, T","year":"2006","journal-title":"J Cancer Res Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1754-9485.2012.02373.x","article-title":"Comparison of radiation treatment delivery for pancreatic cancer: linac intensity-modulated radiotherapy versus helical tomotherapy","volume":"56","author":"Taylor, R","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1118\/1.596958","article-title":"Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy","volume":"20","author":"Mackie, TR","year":"1993","journal-title":"Med Phys"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1245\/s10434-009-0408-6","article-title":"Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement","volume":"16","author":"Callery, MP","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1748-717X-1-23","article-title":"Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes","volume":"1","author":"Combs, SE","year":"2006","journal-title":"Radiat Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ijrobp.2008.06.1483","article-title":"CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy","volume":"73","author":"Koom, WS","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00000658-196909010-00006","article-title":"The natural history and management of radiation induced injury of the gastrointestinal tract","volume":"170","author":"DeCosse, JJ","year":"1969","journal-title":"Ann Surg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4","article-title":"Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group","volume":"48","author":"Moertel, CG","year":"1981","journal-title":"Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/107327480801500404","article-title":"Borderline resectable pancreatic cancer: on the edge of survival","volume":"15","author":"Springett, GM","year":"2008","journal-title":"Cancer Control"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ctrv.2012.09.008","article-title":"Neoadjuvant therapy in resectable pancreatic cancer: a critical review","volume":"39","author":"Belli, C","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"3 Suppl 1","key":"ref23","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.surg.2012.05.029","article-title":"Resection after neoadjuvant therapy for locally advanced, \u201cunresectable\u201d pancreatic cancer","volume":"152","author":"Strobel, O","year":"2012","journal-title":"Surgery"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.23044","article-title":"Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?","volume":"106","author":"Papalezova, KT","year":"2012","journal-title":"J Surg Oncol"},{"key":"ref25","first-page":"378","article-title":"The radiotherapy of pancreatic cancer","volume":"6","author":"Dobelbower, RR","year":"1979","journal-title":"Semin Oncol"},{"key":"ref26","first-page":"157","article-title":"The role of radiotherapy in management of pancreatic cancer","volume":"2","author":"Wang, F","year":"2011","journal-title":"J Gastrointest Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00066-013-0391-5","article-title":"Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer: outcome analysis and comparison with a 3D-treated patient cohort","volume":"189","author":"Combs, SE","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.meddos.2010.08.003","article-title":"A comparison of helical intensity-modulated radiotherapy, intensity-modulated radiotherapy, and 3D-conformal radiation therapy for pancreatic cancer","volume":"36","author":"Poppe, MM","year":"2011","journal-title":"Med Dosim"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ijrobp.2011.10.050","article-title":"High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer","volume":"83","author":"Chang, JS","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ijrobp.2004.05.061","article-title":"A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer","volume":"60","author":"Chung, HW","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.pan.2013.07.064","article-title":"Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer","volume":"13","author":"Cho, IR","year":"2013","journal-title":"Pancreatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.radonc.2011.04.001","article-title":"Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis","volume":"99","author":"Zhu, CP","year":"2011","journal-title":"Radiother Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2011.05.038","article-title":"Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer","volume":"99","author":"Huang, J","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["Gut and Liver"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/ekjg\/ekjg010-02-20.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T12:21:53Z","timestamp":1567254113000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.gutnliver.org\/journal\/view.html?doi=10.5009\/gnl15186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3,23]]}},"alternative-id":["10.5009\/gnl15186"],"URL":"https:\/\/doi.org\/10.5009\/gnl15186","relation":{},"ISSN":["1976-2283","2005-1212"],"issn-type":[{"value":"1976-2283","type":"print"},{"value":"2005-1212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,23]]}}}